SlideShare a Scribd company logo
1 of 21
Heart Failure Guideline Recommendations for Device Therapy and Ejection Fraction (EF) Measurement ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult ( www.acc.org  and  www.americanheart.org ).  Copyright 2005 The American College of Cardiology Foundation and American Heart Association, Inc.  Permission granted for limited use.  Further reproduction is not permitted without permission of the ACC/AHA.
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic HF in the Adult ,[object Object],[object Object],[object Object],[object Object],[object Object]
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic HF ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ACC/AHA Task Force on  Practice Guidelines ,[object Object],[object Object],[object Object]
Heart Failure Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Heart Failure Background Heart Failure At Risk for Heart Failure Stage D Refractory HF requiring specialized interventions Stage B Structural heart disease but without signs or symptoms of HF Stage C Structural heart disease with prior or current HF symptoms Stage A At high risk of HF but without structural heart disease or HF symptoms
[object Object],Structural heart disease but without signs or symptoms of HF:   Patients with previous MI, LV remodeling including LVH and low EF, or asymptomatic valvular disease ,[object Object],Refractory HF requiring specialized interventions:   Patients who have marked symptoms at rest despite maximal medical therapy (e.g., those who are recurrently hospitalized or cannot be safely discharged from the hospital without specialized interventions)  Stage A   Stage B   Stage C   Stage D
2005 Heart Failure Guideline Update  Diagnosis and Management of Chronic HF in Adults -  Devices in Selected Patients - ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2005 Heart Failure Guideline Update  Diagnosis and Management of Chronic HF in Adults -  Devices in Selected Patients -
ACC/AHA Classification of  Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ACC/AHA Level of Evidence   ,[object Object],[object Object],[object Object]
Stage B: ICD Guideline Class IIa, Level of Evidence B ,[object Object],[object Object],[object Object],[object Object],[object Object],Placement of an ICD is reasonable in patients with ,[object Object],[object Object],[object Object],[object Object]
Stage B: ICD Guideline  Class IIb, Level of Evidence C ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Placement of an ICD might be considered in patients ,[object Object],[object Object]
Stage C: ICD Guideline Class I, Level of Evidence A ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],An implantable cardioverter-defibrillator is recommended as secondary prevention to prolong survival in patients with
Stage C: ICD Guideline Class I, Level of Evidence A ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Implantable cardioverter-defibrillator therapy is recommended for primary prevention to reduce total mortality by a reduction in sudden cardiac death in patients with
Stage C: ICD Guideline Class I, Level of Evidence B ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Implantable cardioverter-defibrillator therapy is recommended for primary prevention to reduce total mortality by a reduction in sudden cardiac death in patients with
Stage C: ICD Guideline Class IIa, Level of Evidence B ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Placement of an implantable cardioverter-defibrillator is reasonable in patients with
Stage C: CRT Guideline Class I, Level of Evidence A ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Patients with   should receive cardiac resynchronization therapy unless contraindicated.
Assessment of Patients: EF Measurement  Class I, Level of Evidence C ,[object Object],[object Object],[object Object],Two-dimensional echocardiography with Doppler should be performed  Radionuclide ventriculography can be performed
Assessment of Patients: EF Measurement  Class IIa, Level of Evidence C ,[object Object],[object Object],[object Object],Repeat measurement of EF and the severity of structural remodeling can provide useful information in patients with HF
Stage A: EF Measurement Class I, Level of Evidence C ,[object Object],[object Object],Healthcare providers should perform a noninvasive evaluation of LV function (i.e., LVEF) in patients with ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult ( www.acc.org  and  www.americanheart.org ).  Copyright 2005 The American College of Cardiology Foundation and American Heart Association, Inc.  Permission granted for limited use.  Further reproduction is not permitted without permission of the ACC/AHA.

More Related Content

What's hot

2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...
2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...
2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...ksmalechu
 
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...PROFESSOR DR. MD. TOUFIQUR RAHMAN
 
2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-preventionPHAM HUU THAI
 
2009 ACCF/AHA Heart Failure Guidelines
2009 ACCF/AHA Heart Failure Guidelines2009 ACCF/AHA Heart Failure Guidelines
2009 ACCF/AHA Heart Failure GuidelinesSun Yai-Cheng
 
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...guestaf1e4
 
2010 Guidelines for Management of Spontaneous ICH
2010 Guidelines for Management of Spontaneous ICH2010 Guidelines for Management of Spontaneous ICH
2010 Guidelines for Management of Spontaneous ICHSun Yai-Cheng
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015rajasekar nagarajan
 
2018 evaluation and management of right sided heart failure
2018 evaluation and management of right sided heart failure2018 evaluation and management of right sided heart failure
2018 evaluation and management of right sided heart failureVinh Pham Nguyen
 
Cardiac rehabilitation
Cardiac rehabilitationCardiac rehabilitation
Cardiac rehabilitationSamuel Clover
 
Vulnerable psase in hf syndrome
Vulnerable psase in hf syndrome Vulnerable psase in hf syndrome
Vulnerable psase in hf syndrome Haytham Ghareeb
 
CONGESTIVE CARDIAC FAILURE. PPT
CONGESTIVE CARDIAC FAILURE. PPTCONGESTIVE CARDIAC FAILURE. PPT
CONGESTIVE CARDIAC FAILURE. PPTHAPPYLULLA
 
ACC/AHA 2007 Guidelines for UA & NSTEMI
ACC/AHA 2007 Guidelines for UA & NSTEMIACC/AHA 2007 Guidelines for UA & NSTEMI
ACC/AHA 2007 Guidelines for UA & NSTEMISun Yai-Cheng
 
Kawasaki disease guidelines 2019
Kawasaki disease guidelines 2019Kawasaki disease guidelines 2019
Kawasaki disease guidelines 2019Mohamed Abass
 
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...guestaf1e4
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPasadsoomro1960
 
G dangas jmc-c lurken
G dangas jmc-c lurkenG dangas jmc-c lurken
G dangas jmc-c lurkendwestenberger
 
Part 3, MHFS, how to build MDHFP
Part 3, MHFS, how to build MDHFPPart 3, MHFS, how to build MDHFP
Part 3, MHFS, how to build MDHFPasadsoomro1960
 
ABHM 15 healthy HF living tips
ABHM 15 healthy HF living tipsABHM 15 healthy HF living tips
ABHM 15 healthy HF living tipsasadsoomro1960
 

What's hot (18)

2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...
2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...
2012 accf aha acp_aats_pcna_scai_sts guideline for the diagnosis and manageme...
 
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...
Perioperative Cardiovascular Evaluation for Non-cardiac surgery - Toufiqur Ra...
 
2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention2019 prevention-guideline-slides-gl-prevention
2019 prevention-guideline-slides-gl-prevention
 
2009 ACCF/AHA Heart Failure Guidelines
2009 ACCF/AHA Heart Failure Guidelines2009 ACCF/AHA Heart Failure Guidelines
2009 ACCF/AHA Heart Failure Guidelines
 
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...
Economic And Humanistic Outcomes Of Post Acs In Cardiac Rehabilitation Progra...
 
2010 Guidelines for Management of Spontaneous ICH
2010 Guidelines for Management of Spontaneous ICH2010 Guidelines for Management of Spontaneous ICH
2010 Guidelines for Management of Spontaneous ICH
 
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
Non cardaic surgery preoperative cardiac evaluation aha esc guideline 2015
 
2018 evaluation and management of right sided heart failure
2018 evaluation and management of right sided heart failure2018 evaluation and management of right sided heart failure
2018 evaluation and management of right sided heart failure
 
Cardiac rehabilitation
Cardiac rehabilitationCardiac rehabilitation
Cardiac rehabilitation
 
Vulnerable psase in hf syndrome
Vulnerable psase in hf syndrome Vulnerable psase in hf syndrome
Vulnerable psase in hf syndrome
 
CONGESTIVE CARDIAC FAILURE. PPT
CONGESTIVE CARDIAC FAILURE. PPTCONGESTIVE CARDIAC FAILURE. PPT
CONGESTIVE CARDIAC FAILURE. PPT
 
ACC/AHA 2007 Guidelines for UA & NSTEMI
ACC/AHA 2007 Guidelines for UA & NSTEMIACC/AHA 2007 Guidelines for UA & NSTEMI
ACC/AHA 2007 Guidelines for UA & NSTEMI
 
Kawasaki disease guidelines 2019
Kawasaki disease guidelines 2019Kawasaki disease guidelines 2019
Kawasaki disease guidelines 2019
 
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...
The Clinical Pharmacist in Cardiac Rehabilitation Phase I at Sarawak General ...
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFP
 
G dangas jmc-c lurken
G dangas jmc-c lurkenG dangas jmc-c lurken
G dangas jmc-c lurken
 
Part 3, MHFS, how to build MDHFP
Part 3, MHFS, how to build MDHFPPart 3, MHFS, how to build MDHFP
Part 3, MHFS, how to build MDHFP
 
ABHM 15 healthy HF living tips
ABHM 15 healthy HF living tipsABHM 15 healthy HF living tips
ABHM 15 healthy HF living tips
 

Viewers also liked

Informe de prã¡ctica 2
Informe de prã¡ctica  2Informe de prã¡ctica  2
Informe de prã¡ctica 2Lissette0107
 
Bloque Simpatico Lumbar
Bloque Simpatico LumbarBloque Simpatico Lumbar
Bloque Simpatico Lumbarguest1dfd53
 
Seminario farmaco s. aureus 3
Seminario farmaco s. aureus 3Seminario farmaco s. aureus 3
Seminario farmaco s. aureus 3Betty Palacios
 
Lupus eritematoso sistematico
Lupus eritematoso sistematico Lupus eritematoso sistematico
Lupus eritematoso sistematico Gabo Carrillo
 
Presentación Estudio RECIPE, Sociedad Española de Arterioscleroris
Presentación Estudio RECIPE, Sociedad Española de ArteriosclerorisPresentación Estudio RECIPE, Sociedad Española de Arterioscleroris
Presentación Estudio RECIPE, Sociedad Española de ArteriosclerorisLa SEA
 
3 antigen antibodybreaction
3  antigen antibodybreaction3  antigen antibodybreaction
3 antigen antibodybreactionNEHALAHMED_NOUH
 

Viewers also liked (12)

FIPH Account 2014 09 19
FIPH Account 2014 09 19 FIPH Account 2014 09 19
FIPH Account 2014 09 19
 
Deltron
DeltronDeltron
Deltron
 
Informe de prã¡ctica 2
Informe de prã¡ctica  2Informe de prã¡ctica  2
Informe de prã¡ctica 2
 
Bloque Simpatico Lumbar
Bloque Simpatico LumbarBloque Simpatico Lumbar
Bloque Simpatico Lumbar
 
Seminario farmaco s. aureus 3
Seminario farmaco s. aureus 3Seminario farmaco s. aureus 3
Seminario farmaco s. aureus 3
 
Acuaterrario
AcuaterrarioAcuaterrario
Acuaterrario
 
New and improved meningitis
New and improved meningitisNew and improved meningitis
New and improved meningitis
 
Presentación1
Presentación1Presentación1
Presentación1
 
Lupus eritematoso sistematico
Lupus eritematoso sistematico Lupus eritematoso sistematico
Lupus eritematoso sistematico
 
Sem 10 s.sjoegren
Sem 10 s.sjoegrenSem 10 s.sjoegren
Sem 10 s.sjoegren
 
Presentación Estudio RECIPE, Sociedad Española de Arterioscleroris
Presentación Estudio RECIPE, Sociedad Española de ArteriosclerorisPresentación Estudio RECIPE, Sociedad Española de Arterioscleroris
Presentación Estudio RECIPE, Sociedad Española de Arterioscleroris
 
3 antigen antibodybreaction
3  antigen antibodybreaction3  antigen antibodybreaction
3 antigen antibodybreaction
 

Similar to Guidelinesummary 1233741531011848-1

The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...
The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...
The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...DrGoharMushtaq
 
2022 Heart Failure Guideline Slide Set.pptx
2022 Heart Failure Guideline Slide Set.pptx2022 Heart Failure Guideline Slide Set.pptx
2022 Heart Failure Guideline Slide Set.pptxsubhankar16
 
CHF guidelines 2013 seminar by Dr manish Ruhela
CHF guidelines 2013 seminar by Dr manish RuhelaCHF guidelines 2013 seminar by Dr manish Ruhela
CHF guidelines 2013 seminar by Dr manish Ruhelamanishdmcardio
 
Heart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHeart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHealth Catalyst
 
ACCF / AHA Guideline for the Management of Heart Failure
ACCF / AHA Guideline for the Management of Heart FailureACCF / AHA Guideline for the Management of Heart Failure
ACCF / AHA Guideline for the Management of Heart Failuredrucsamal
 
Imbaba acs guidelines 2012
Imbaba acs guidelines 2012Imbaba acs guidelines 2012
Imbaba acs guidelines 2012Amir Mahmoud
 
Optimizing heart failure management
Optimizing heart failure managementOptimizing heart failure management
Optimizing heart failure managementikramdr01
 
The Problem Of Heart Failure
The Problem Of Heart FailureThe Problem Of Heart Failure
The Problem Of Heart Failurefmaklady
 
Heart failure
Heart failureHeart failure
Heart failureEla Maran
 
Heart_Failure
Heart_FailureHeart_Failure
Heart_FailureEbru65
 
Heart Faliure Management Guide Lines
Heart Faliure Management Guide LinesHeart Faliure Management Guide Lines
Heart Faliure Management Guide LinesSuneth Weerarathna
 
Device therapy in heart failure
Device therapy in  heart failureDevice therapy in  heart failure
Device therapy in heart failureRAJ SINGH
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Hossam atef
 
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxSURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxhospital
 
Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyImran Ahmed
 
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptxSpandanaRallapalli
 

Similar to Guidelinesummary 1233741531011848-1 (20)

The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...
The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...
The New Standard of Care__Leveraging the Benefits of SGLT2 Inhibitors Across ...
 
2022 Heart Failure Guideline Slide Set.pptx
2022 Heart Failure Guideline Slide Set.pptx2022 Heart Failure Guideline Slide Set.pptx
2022 Heart Failure Guideline Slide Set.pptx
 
CHF guidelines 2013 seminar by Dr manish Ruhela
CHF guidelines 2013 seminar by Dr manish RuhelaCHF guidelines 2013 seminar by Dr manish Ruhela
CHF guidelines 2013 seminar by Dr manish Ruhela
 
Heart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your ReachHeart Failure Care: How World-Class Performance is Within Your Reach
Heart Failure Care: How World-Class Performance is Within Your Reach
 
ACCF / AHA Guideline for the Management of Heart Failure
ACCF / AHA Guideline for the Management of Heart FailureACCF / AHA Guideline for the Management of Heart Failure
ACCF / AHA Guideline for the Management of Heart Failure
 
Imbaba acs guidelines 2012
Imbaba acs guidelines 2012Imbaba acs guidelines 2012
Imbaba acs guidelines 2012
 
Optimizing heart failure management
Optimizing heart failure managementOptimizing heart failure management
Optimizing heart failure management
 
The Problem Of Heart Failure
The Problem Of Heart FailureThe Problem Of Heart Failure
The Problem Of Heart Failure
 
5666367.ppt
5666367.ppt5666367.ppt
5666367.ppt
 
Heart failure
Heart failureHeart failure
Heart failure
 
Heart_Failure
Heart_FailureHeart_Failure
Heart_Failure
 
Heart Faliure Management Guide Lines
Heart Faliure Management Guide LinesHeart Faliure Management Guide Lines
Heart Faliure Management Guide Lines
 
Marcapasos reusados
Marcapasos reusadosMarcapasos reusados
Marcapasos reusados
 
Marcapasos reusados
Marcapasos reusadosMarcapasos reusados
Marcapasos reusados
 
Samir rafla acute heart failure- guidelines 2017
Samir rafla  acute heart failure- guidelines 2017Samir rafla  acute heart failure- guidelines 2017
Samir rafla acute heart failure- guidelines 2017
 
Device therapy in heart failure
Device therapy in  heart failureDevice therapy in  heart failure
Device therapy in heart failure
 
Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1Pre operative cardiac assessment dr sadany-1
Pre operative cardiac assessment dr sadany-1
 
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxSURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
 
Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device Therapy
 
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx
2022-Heart failure ACC/AHA guidelines, comparison with ECS in the end.pptx
 

More from Carlo Favaretti

Tackling wasteful-spending-on-health-highlights-revised OECD
Tackling wasteful-spending-on-health-highlights-revised OECDTackling wasteful-spending-on-health-highlights-revised OECD
Tackling wasteful-spending-on-health-highlights-revised OECDCarlo Favaretti
 
Fuffa questa? svegliatevi gentiluomini garantisti! il foglio
Fuffa questa? svegliatevi gentiluomini garantisti!   il foglioFuffa questa? svegliatevi gentiluomini garantisti!   il foglio
Fuffa questa? svegliatevi gentiluomini garantisti! il foglioCarlo Favaretti
 
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...Carlo Favaretti
 
La spoon river della sinistra l'espresso
La spoon river della sinistra   l'espressoLa spoon river della sinistra   l'espresso
La spoon river della sinistra l'espressoCarlo Favaretti
 
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...Carlo Favaretti
 
I migranti di tito boeri il foglio
I migranti di tito boeri   il foglioI migranti di tito boeri   il foglio
I migranti di tito boeri il foglioCarlo Favaretti
 
Vaccini cattaneo in senato
Vaccini cattaneo in senatoVaccini cattaneo in senato
Vaccini cattaneo in senatoCarlo Favaretti
 
Decreto vaccinazioni 2017 20commenti
Decreto vaccinazioni 2017   20commentiDecreto vaccinazioni 2017   20commenti
Decreto vaccinazioni 2017 20commentiCarlo Favaretti
 
Festival trento salute_disuguale_programma
Festival trento salute_disuguale_programmaFestival trento salute_disuguale_programma
Festival trento salute_disuguale_programmaCarlo Favaretti
 
Guida al grande romanzo epico dell’europa il foglio
Guida al grande romanzo epico dell’europa   il foglioGuida al grande romanzo epico dell’europa   il foglio
Guida al grande romanzo epico dell’europa il foglioCarlo Favaretti
 
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...Carlo Favaretti
 
Trump’s pox americana | foreign policy
Trump’s pox americana | foreign policyTrump’s pox americana | foreign policy
Trump’s pox americana | foreign policyCarlo Favaretti
 
Come distinguere l'innovazione dal nuovo? | sanità24 il sole 24 ore
Come distinguere l'innovazione dal nuovo? | sanità24   il sole 24 oreCome distinguere l'innovazione dal nuovo? | sanità24   il sole 24 ore
Come distinguere l'innovazione dal nuovo? | sanità24 il sole 24 oreCarlo Favaretti
 
Tar fvg punto nascita h latisana
Tar fvg punto nascita h latisanaTar fvg punto nascita h latisana
Tar fvg punto nascita h latisanaCarlo Favaretti
 
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri il...
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri   il...Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri   il...
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri il...Carlo Favaretti
 

More from Carlo Favaretti (20)

Bill gates investimenti
Bill gates investimentiBill gates investimenti
Bill gates investimenti
 
Tackling wasteful-spending-on-health-highlights-revised OECD
Tackling wasteful-spending-on-health-highlights-revised OECDTackling wasteful-spending-on-health-highlights-revised OECD
Tackling wasteful-spending-on-health-highlights-revised OECD
 
Ottimismo cerasa
Ottimismo cerasaOttimismo cerasa
Ottimismo cerasa
 
Fuffa questa? svegliatevi gentiluomini garantisti! il foglio
Fuffa questa? svegliatevi gentiluomini garantisti!   il foglioFuffa questa? svegliatevi gentiluomini garantisti!   il foglio
Fuffa questa? svegliatevi gentiluomini garantisti! il foglio
 
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...
Governo m5s lega, previsioni (con flaubert) sul governo vattelappesca - il fo...
 
La spoon river della sinistra l'espresso
La spoon river della sinistra   l'espressoLa spoon river della sinistra   l'espresso
La spoon river della sinistra l'espresso
 
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...
Tutti i problemi giornalistici e scientifici del libro sui vaccini di giulia ...
 
Tarallo privacy
Tarallo privacyTarallo privacy
Tarallo privacy
 
I migranti di tito boeri il foglio
I migranti di tito boeri   il foglioI migranti di tito boeri   il foglio
I migranti di tito boeri il foglio
 
Vaccini cattaneo in senato
Vaccini cattaneo in senatoVaccini cattaneo in senato
Vaccini cattaneo in senato
 
Vaccini opuscolo
Vaccini opuscoloVaccini opuscolo
Vaccini opuscolo
 
Progr 10°cong sihta
Progr 10°cong sihtaProgr 10°cong sihta
Progr 10°cong sihta
 
Decreto vaccinazioni 2017 20commenti
Decreto vaccinazioni 2017   20commentiDecreto vaccinazioni 2017   20commenti
Decreto vaccinazioni 2017 20commenti
 
Festival trento salute_disuguale_programma
Festival trento salute_disuguale_programmaFestival trento salute_disuguale_programma
Festival trento salute_disuguale_programma
 
Guida al grande romanzo epico dell’europa il foglio
Guida al grande romanzo epico dell’europa   il foglioGuida al grande romanzo epico dell’europa   il foglio
Guida al grande romanzo epico dell’europa il foglio
 
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...
Chi ha trasformato l’appello al popolo in una mozione di sfiducia alla democr...
 
Trump’s pox americana | foreign policy
Trump’s pox americana | foreign policyTrump’s pox americana | foreign policy
Trump’s pox americana | foreign policy
 
Come distinguere l'innovazione dal nuovo? | sanità24 il sole 24 ore
Come distinguere l'innovazione dal nuovo? | sanità24   il sole 24 oreCome distinguere l'innovazione dal nuovo? | sanità24   il sole 24 ore
Come distinguere l'innovazione dal nuovo? | sanità24 il sole 24 ore
 
Tar fvg punto nascita h latisana
Tar fvg punto nascita h latisanaTar fvg punto nascita h latisana
Tar fvg punto nascita h latisana
 
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri il...
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri   il...Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri   il...
Raggi e il vertice farsa con beppe grillo. qualcuno chiami i carabinieri il...
 

Guidelinesummary 1233741531011848-1

  • 1. Heart Failure Guideline Recommendations for Device Therapy and Ejection Fraction (EF) Measurement ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult ( www.acc.org and www.americanheart.org ). Copyright 2005 The American College of Cardiology Foundation and American Heart Association, Inc. Permission granted for limited use. Further reproduction is not permitted without permission of the ACC/AHA.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Heart Failure Background Heart Failure At Risk for Heart Failure Stage D Refractory HF requiring specialized interventions Stage B Structural heart disease but without signs or symptoms of HF Stage C Structural heart disease with prior or current HF symptoms Stage A At high risk of HF but without structural heart disease or HF symptoms
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.

Editor's Notes

  1. ACC/AHA have been two of the leading forces in creating guidelines for the implantation of pacemakers and ICDs. The most recently published guidelines were published in Sept/Oct 2002. Many other countries have used these guidelines as a model to revise their own guidelines for ICD and pacemaker implantation. (In addition to the classification in Class I, II, or III, each indication has a level of evidence, based on the volume of literature published on the subject.)
  2. All recommendations assume that patients meet all the bulleted requirements, unless otherwise indicated by an “or” in the statement.